Back to Search Start Over

108 Are we doing what we can to prevent preeclampsia?

Authors :
Thais Farias Portugal
Thaís Travassos da Silva
Keliany Carla Duarte de Araújo
Henri Augusto Korkes
Nelson Sass
Nayanne Silva da Fonseca
Elisa Chalem
Source :
Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health. 6:231-232
Publication Year :
2016
Publisher :
Elsevier BV, 2016.

Abstract

Introduction Preeclampsia (PE) is an important cause to maternal and perinatal morbimortality. The usage of acetylsalicylic acid (ASA) and Calcium (Ca) has been recommended to risk patients’ groups as preventive measures. Amongst the preeclampsia developing risk groups there are primiparous patients. However, we verified that this kind of intervention has been barely done in Sao Paulo and it seems not to be changed despite the consistent evidence to recommend its usage. Objectives Evaluate the ASA and Ca prescription frequency to primiparous patients. Methodology A comparative and retrospective study between two groups of primiparous patients was conducted. Firstly, all primiparous patients who have developed preeclampsia between January and May of 2016 and whose child-birth happened in Hospital Maternidade Vila Nova Cachoeirinha (HMEC) in Sao Paulo were identified through records evaluation and prenatal care portfolio. After that, a control group of primiparous patients who did not present any pathology during the gestation period was chosen and they were paired accordingly to their maternal age and gestational age at the child-birth. Results From that 23 primiparous pregnant woman with preeclampsia, 17.4% took ASA; 8.7% took Ca. Amongst the primiparous who did not develop preeclampsia, 2% took ASA; 12.2% took Ca and 2% took both medications (Table 1). There were no significant differences among the groups (p = 0.094). Conclusion Despite the consistent evidences for the usage of ASA and Ca, apparently the primary care in Sao Paulo city did not widely incorporate the recommendation of preventive measures to PE among high-risk patients. It is possible to assume that this behavior standard is similar among patients with other risk factors. Considering the strategic matter of prenatal care, that observation can be taken as a first step in order to enlarge this analysis and guide public policies to increase the usage of ASA and Ca in PE-risk patients. The authors thank the support FAPESP 2014.00213/7.

Details

ISSN :
22107789
Volume :
6
Database :
OpenAIRE
Journal :
Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health
Accession number :
edsair.doi...........941a4b06303e4c6baef28432374a39b9
Full Text :
https://doi.org/10.1016/j.preghy.2016.08.190